Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market
Holding DSGN?
Track your performance easily

Design Therapeutics (DSGN) Financial Statements

82 Followers

Design Therapeutics Financial Overview

Design Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.898; its P/E ratio is -6.49; Design Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -13.04M$ -11.79M$ -14.40M$ -15.12M$ -18.82M
EBITDA$ -12.88M$ -9.91M$ -14.26M$ -14.98M$ -18.68M
Net Income Common Stockholders$ -13.04M$ -11.79M$ -11.11M$ -11.84M$ -15.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 254.07M$ 261.02M$ 270.69M$ 281.80M$ 290.94M
Total Assets$ 261.63M$ 269.58M$ 278.79M$ 289.64M$ 299.87M
Total Debt$ 1.74M$ 1.95M$ 2.14M$ 2.33M$ 2.52M
Net Debt$ -252.33M$ -259.07M$ -268.54M$ -279.46M$ -288.42M
Total Liabilities$ 9.18M$ 8.34M$ 9.24M$ 11.96M$ 14.91M
Stockholders Equity$ 252.45M$ 261.27M$ 269.59M$ 277.69M$ 284.96M
Cash Flow-
Free Cash Flow$ -9.53M$ -11.42M$ -12.63M$ -12.82M$ -14.59M
Operating Cash Flow$ -9.55M$ -11.26M$ -12.44M$ -12.80M$ -14.53M
Investing Cash Flow$ -5.83M$ 27.33M$ 20.62M$ 5.55M$ 15.27M
Financing Cash Flow$ 1.00K$ 229.00K$ 20.00K$ 501.00K$ 13.00K
Currency in USD

Design Therapeutics Earnings and Revenue History

Design Therapeutics Debt to Assets

Design Therapeutics Cash Flow

Design Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis